Insulin-like growth factor-1 in myocardial tissue: Interaction with tumor necrosis factor

Critical Care

Volumn 7, Issue 6, 2003, Pages 417-419

  Wang, Meijing ^a   Tsai, Ben ^a   Brown, John W ^a   Meldrum, Daniel R ^a  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CELL NUCLEUS DNA; MITOCHONDRIAL DNA; PROTEIN BAX; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TUMOR NECROSIS FACTOR;

ARTICLE; CARDIOVASCULAR DISEASE; CELL DEATH; CELL PROTECTION; CELL SURVIVAL; ENZYME ACTIVATION; HEART DISEASE; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PERFORMANCE; HEART PROTECTION; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN INDUCTION; RECEPTOR BINDING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TISSUE GROWTH;

ANIMALS; CELL SURVIVAL; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MICE; RECEPTOR, IGF TYPE 1; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0348161252     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc2387     Document Type: Article

References (17)

1. Davani EY, Brumme Z, Singhera GK, Cote HCF, Harrigan PR, Dorscheid DR: Insulin-like growth factor-1 protects ischemic murine myocardium from ischemia/reperfusion associated injury. Crit Care 2003, 7:R176-R183.
2. Buerke M, Murohara T, Skurk C, Nuss C, Tomaselli K, Lefer AM: Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci USA 1995, 92:8031-8035.
3. Yamamura T, Otani H, Nakao Y, Hattori R, Osako M, Imamura H: IGF-I differentially regulates Bcl-xL and Bax and confers myocardial protection in the rat heart. Am J Physiol Heart Circ Physiol 2001, 280:H1191-H1200.
4. Fujio Y, Nguyen T, Wencker D, Kitsis RN, Walsh K: Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 2000, 101:660-667.
5. Otani H, Yamamura T, Nakao Y, Hattori R, Kawaguchi H, Osako M, Imamura H: Insulin-like growth factor-I improves recovery of cardiac performance during reperfusion in isolated rat heart by a wortmannin-sensitive mechanism. J Cardiovasc Pharmacol 2000, 35:275-281.
6. Yamashita K, Kajstura J, Discher DJ, Wasserlauf BJ, Bishopric NH, Anversa P, Webster KA: Reperfusion-activated Akt kinase prevents apoptosis in transgenic mouse hearts overexpressing insulin-like growth factor-1. Circ Res 2001, 88:609-614.
7. Wu W, Lee W, Wu Y, Chen D, Liu T, Sharma PM, Wang PH: Expression of constitutively active phosphatidylinositol 3 kinase inhibits activation of caspase 3 and apoptosis of cardiac muscle cells. J Biol Chem 2000, 275:40113-40119.
8. Hong F, Kwon SJ, Jhun BS, Kim SS, Ha J, Kim SJ, Sohn NW, Kang C, Kang I: Insulin-like growth factor-1 protects H9c2 cardiac myoblasts from oxidative stress-induced apoptosis via phosphatidylinositol 3-kinase and extracellular signal-regulated kinase pathways. Life Sci 2001, 68:1095-1105.
9. Che W, Lerner-Marmarosh N, Huang Q, Osawa M, Ohta S, Yoshizumi M, Glassman M, Lee JD, Yan C, Berk BC, Abe J: Insulin-like growth factor-1 enhances inflammatory responses in endothelial cells: role of Gab1 and MEKK3 in TNF-alpha-induced c-Jun and NF-kappaB activation and adhesion molecule expression. Circ Res 2002, 90:1222-1230.
10. Meldrum DR: Tumor necrosis factor in the heart. Am J Physiol 1998, 274:R577-R595.
11. Niebauer J, Pflaum CD, Clark AL, Strasburger CJ, Hooper J, Poole-Wilson PA, Coats AJ, Anker SD: Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation. J Am Coll Cardiol 1998, 32:393-397.
12. Fan J, Li YH, Bagby GJ, Lang CH: Modulation of inflammation-induced changes in insulin-like growth factor (IGF)-I and IGF binding protein-1 by anti-TNF antibody. Shock 1995, 4:21-26.
13. Anwar A, Zahid AA, Scheidegger KJ, Brink M, Delafontaine P: Tumor necrosis factor-alpha regulates insulin-like growth factor-1 and insulin-like growth factor binding protein-3 expression in vascular smooth muscle. Circulation 2002, 105: 1220-1225.
14. Frost RA, Nystrom GJ, Lang CH: Tumor necrosis factor-alpha decreases insulin-like growth factor-I messenger ribonucleic acid expression in C2C12 myoblasts via a Jun N-terminal kinase pathway. Endocrinology 2003, 144:1770-1779.
15. Vallee S, Fouchier F, Bremond P, Briand C, Marvaldi J, Champion S: Insulin-like growth factor-1 downregulates nuclear factor kappa B activation and upregulates interleukin-8 gene expression induced by tumor necrosis factor alpha. Biochem Biophys Res Commun 2003, 305:831-839.
16. 2+ through a wortmannin-sensitive pathway: studies in rat and ferret isolated muscles. Circ Res 1998, 83:50-59.
17. 2+ and NO. Am J Physiol 1998, 275:H823-H830.